This is a study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics
(PD) and anti-tumor activity of DS-1001b in patients with gliomas that harbor IDH1-R132
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT03030066
Ages eligible for Study
20 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Has histologically confirmed glioma with an IDH1-R132 mutation
Has disease that has recurred or progressed following standard treatment including radiotherapy
Has measurable lesion(s) as per RANO criteria
Has Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
Has significant symptoms of increased intracranial pressure
Has another active neoplasm
Has active infection requiring systemic treatment
Has a history of severe cardiac disease
Has had prior treatment with any inhibitor targeting mutant IDH1
Has had investigational drug treatment within 4 weeks prior to the first dose of study treatment
Is a pregnant or lactating female
All locations for NCT03030066
National Cancer Center Hospital
View full eligibility
Tris trial is registered with FDA with number: NCT03030066. The sponsor of the trial is Daiichi Sankyo Co., Ltd. and it is looking for 60 volunteers for the current phase.
Official trial title: A Phase 1 Study of DS-1001b in Patients With IDH1 Mutated Gliomas
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
Consult your doctor?
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.